SNSESensei Biotherapeutics, Inc.

SNSE Stock Price, Valuation & Chart | Sensei Biotherapeutics, Inc.

Compare

$13.850-3.97 (-22.28%)

At close · 15 June 2026, 08:00 pm

Sector: Healthcare Industry: Biotechnology SNSE intrinsic value SNSE calculated fair value vs price

Overview Financials Dividends Ratios

SNSE Historical price chart

SNSE Key Stats

Fair Value

Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock

Market Capitalization18.59M

PE Ratio-0.1

EPS-142.7

Trading Volume219.47K

Today's High/Low16.52/13.76

Dividend Yield0.00

52 Week High/Low36.76/6.33

Shares Outstanding1.34M

SNSE Financial Statement

SNSE Analyst ratings

SNSE Analysis & performance metrics

SNSE Company profile

Sensei Biotherapeutics, Inc., a biopharmaceutical company, engages in the discovery and development of immunotherapies with an initial focus on treatments for cancer. It…

Sensei Biotherapeutics, Inc., a biopharmaceutical company, engages in the discovery and development of immunotherapies with an initial focus on treatments for cancer. It develops proprietary ImmunoPhage platform, an immunotherapy approach that is designed to utilize bacteriophage to induce a focused and coordinated innate and adaptive immune response; and Tumor Microenvironment…

SNSE Management team

Name

Position

Lora Pike

Vice President of Investor Relations & Communications

Edward Van der Horst Ph.D.

Chief Scientific Officer

Stephanie Krebs M.B.A., M.S.

Chief Business Officer

John K. Celebi M.B.A.CEO

President, Chief Executive Officer & Director

Christopher W. Gerry J.D.

Senior Vice President, General Counsel & Secretary

Josiah Craver

Senior Vice President of Finance, Principal Financial Officer & Principal Accounting Officer

Aaron Weitzman FACP, M.D., Ph.D.

Chief Medical Officer

Name

Position

Lora Pike

Vice President of Investor Relations & Communications

Edward Van der Horst Ph.D.

Chief Scientific Officer

Stephanie Krebs M.B.A., M.S.

Chief Business Officer

John K. Celebi M.B.A.CEO

President, Chief Executive Officer & Director

Christopher W. Gerry J.D.

Senior Vice President, General Counsel & Secretary

Josiah Craver

Senior Vice President of Finance, Principal Financial Officer & Principal Accounting Officer

Aaron Weitzman FACP, M.D., Ph.D.

Chief Medical Officer

Management Team

Lora Pike

Vice President of Investor Relations & Communications

Edward Van der Horst Ph.D.

Chief Scientific Officer

Stephanie Krebs M.B.A., M.S.

Chief Business Officer

John K. Celebi M.B.A.CEO

President, Chief Executive Officer & Director

Christopher W. Gerry J.D.

Senior Vice President, General Counsel & Secretary

Josiah Craver

Senior Vice President of Finance, Principal Financial Officer & Principal Accounting Officer

Aaron Weitzman FACP, M.D., Ph.D.

Chief Medical Officer

Management

Lora Pike

Vice President of Investor Relations & Communications

Edward Van der Horst Ph.D.

Chief Scientific Officer

Stephanie Krebs M.B.A., M.S.

Chief Business Officer

John K. Celebi M.B.A.CEO

President, Chief Executive Officer & Director

Christopher W. Gerry J.D.

Senior Vice President, General Counsel & Secretary

Josiah Craver

Senior Vice President of Finance, Principal Financial Officer & Principal Accounting Officer

Aaron Weitzman FACP, M.D., Ph.D.

Chief Medical Officer

Total 7 executives

SNSE Frequently asked questions

What is Sensei Biotherapeutics, Inc. (SNSE) Stock Price?

Current stock price of Sensei Biotherapeutics, Inc. (SNSE) stock is $13.850. The stock price is -22.28% lower in the session. The intraday range can be seen from this page. Volume of Sensei Biotherapeutics, Inc. (SNSE) stock is 219.47K.

Last updated at 15 June 2026, 08:00 pm.

Why is the Sensei Biotherapeutics, Inc. (SNSE) stock price going up or down today?

The stock price of Sensei Biotherapeutics, Inc. (SNSE) can change with earnings, company news, and overall market sentiment. Sensei Biotherapeutics, Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Sensei Biotherapeutics, Inc. stock expensive at its current price?

Whether Sensei Biotherapeutics, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for SNSE on this page is -0.10. EPS on this page is -142.72. Compare those figures with peers and growth expectations before deciding if the current Sensei Biotherapeutics, Inc. price is justified.

How has the stock price of Sensei Biotherapeutics, Inc. (SNSE) performed historically?

Historical performance for Sensei Biotherapeutics, Inc. (SNSE) is shown on the price chart on this page. Review multi-period moves alongside volume to see how SNSE reacted to past earnings and market events.

Should I buy Sensei Biotherapeutics, Inc. (SNSE) stock, at this price?

Buying Sensei Biotherapeutics, Inc. (SNSE) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.